Viewing nowCombinationAmostar Tablet 40/5 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
(Co., Ltd.) CMG Pharmaceutical

MFDS item code 201605763 · Approved 2016.09.30 · Insurance code 648603380
Treatment of essential hypertension not controlled with monotherapy
This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of amlodipine or telmisartan. This drug effectively lowers blood pressure, reducing the risk of cardiovascular complications and aiding in blood pressure management. Therefore, it plays an important role in the treatment of essential hypertension.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that the tablet be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, as follows, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 milligrams). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
○ Pediatric patients: As the safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger, its use is not recommended.
This medication should not be used during pregnancy, especially in the second and third trimesters, as it may pose serious risks to the fetus. It should be discontinued as soon as pregnancy is confirmed. This medication should not be administered to patients with allergies to specific components, severe liver dysfunction, severe hypotension, or serious heart-related diseases. Additionally, this drug should not be used in pregnant or nursing women or patients with biliary obstructive disease. Patients with primary aldosteronism or specific heart valve diseases should use this medication cautiously, and patients with liver impairment may require dosage adjustments and close monitoring. Patients with gastrointestinal diseases, renal artery hypertension, renal failure, and elderly patients should use this medication with special caution. Common side effects can include dizziness and peripheral edema, with serious side effects occurring rarely. Symptoms of hypotension may present; appropriate measures are necessary when such symptoms occur. There is a risk of elevated potassium levels in the blood, so potassium levels should be checked regularly, and caution is necessary when used in conjunction with potassium-containing medications. Patients with heart diseases should use this medication cautiously as it may increase the risk of angina or myocardial infarction. This medication may cause drowsiness or dizziness; caution is needed when driving or operating hazardous machinery. This medication may interact with other specific drugs; if there are co-administered medications, it is crucial to consult with a doctor or pharmacist. Pregnant or nursing women should avoid using this medication, and especially during breastfeeding, it is safest not to use this medication. The safety and efficacy of this drug in pediatric patients have not been established, thus its use is not recommended. Elderly patients may be more sensitive to this medication, requiring careful dosage adjustments. In cases of overdose, symptoms such as hypotension, dizziness, and heart issues may occur, necessitating immediate medical assistance. This medication should be kept out of reach of children, and it is advisable not to change the packaging for storage. The packaging should not be opened until just before administration to maintain the quality of the drug.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that protects from light, in a temperature range of 1 to 30 degrees Celsius. Storing it this way helps maintain its efficacy and safety.
A white and light gray, double convex, oval-shaped tablet.
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
(Co., Ltd.) CMG Pharmaceutical
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.